Training Immune Cells to Be Cancer Killers

A career-altering experience as a cancer patient motivated one researcher to design more potent immunotherapies.

Written byAparna Nathan, PhD
| 4 min read
800x560 istock image
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For Christian Hinrichs, an oncologist who leads the cancer immunotherapy division at the Rutgers Cancer Institute, the search for effective treatments is more than just an interesting scientific question—it is a personal one. His own bout with cancer more than a decade earlier made him acutely aware of just how important it is to find therapies that completely eliminate tumors, steering his research toward engineering patients’ own cells to find and kill cancer cells and running clinical trials to bring these treatments into practice.

I trained initially as a general surgeon, but after I finished my training, I recognized the limitations of surgery, especially in the setting of advanced cancers, so I started conducting research on tumor immunology. But my research wasn’t as clinically applicable as I wanted it to be because it did not address the types of cancer being treated in the clinic where it could make the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Aparna Nathan, PhD

    Aparna is a freelance science writer with a PhD in bioinformatics and genomics from Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular Science, PBS NOVA, and The Open Notebook.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH